Surveillance of infant pertussis in Sweden 1998–2012; severity of disease in relation to the national vaccination programme
Authors:
Open Access
- 12 February 2015
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 20 (6) , 21032-13
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matchesKeywords
This publication has 16 references indexed in Scilit:
- Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?Vaccine, 2013
- Estimating the burden of pertussis in young children on hospitals and emergency departments: a study using linked routinely collected dataEpidemiology and Infection, 2013
- Accelerating Control of Pertussis in England and WalesEmerging Infectious Diseases, 2012
- Pertussis after end of a mass vaccination project—End of the “vaccination honey-moon”Vaccine, 2011
- SEVERE PERTUSSIS IN INFANTSThe Pediatric Infectious Disease Journal, 2011
- Seroprevalence of pertussis antitoxin (anti‐PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination programAPMIS, 2009
- Control of pertussis—Lessons learnt from a 10-year surveillance programme in SwedenVaccine, 2009
- Pertussis Hospitalizations Among Infants in the United States, 1993 to 2004Pediatrics, 2008
- Long-term Follow-up of Swedish Children Vaccinated With Acellular Pertussis Vaccines at 3, 5, and 12 Months of Age Indicates the Need for a Booster Dose at 5 to 7 Years of AgePediatrics, 2006
- Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccineVaccine, 2003